Relationship between IL-6 and COVID-19: to be considered during treatment-Reference-Cited by-同舟云学术

Relationship between IL-6 and COVID-19: to be considered during treatment

Published:2020-12 Issue:12 Volume:15 Page:817-822
ISSN:1746-0794
Container-title:Future Virology
language:en
Short-container-title:Future Virology

Author:

Vatansever Hafize Seda¹²^ORCID,Becer Eda²³^ORCID

Affiliation:

1. Department of Histology & Embryology, Faculty of Medicine, Manisa Celal Bayar University, Manisa, Turkey

2. DESAM Institute, Near East University, Nicosia, Mersin 10 Turkey

3. Department of Biochemistry, Faculty of Pharmacy, Near East University, Nicosia, Mersin 10 Turkey

Abstract

The detection and control of pro-inflammatory response is crucial in the early stages of viral infection. Coronavirus disease 2019 (COVID-19) is an emerging viral disease of global concern and optimal treatment has yet to be determined. Unknown response of treatment of COVID-19 is important during patient monitoring. IL-6 is one of the key cytokines after activated macrophages. Therefore, control of systemic IL-6 levels in SARS-CoV-2 infected patients may be a parameter for COVID-19 disease. This review is focused on the induction of IL-6 after viral infections as a target molecule for monitoring cellular response.

Publisher

Future Medicine Ltd

Subject

Virology

Link

https://www.futuremedicine.com/doi/pdf/10.2217/fvl-2020-0168

Reference37 articles.

1. Interleukin-6 and the acute phase response

2. Pathogen Recognition by the Innate Immune System

3. The Two-Faced Cytokine IL-6 in Host Defense and Diseases

4. Transmissible Gastroenteritis Virus Infection Up-Regulates FcRn Expression via Nucleocapsid Protein and Secretion of TGF-β in Porcine Intestinal Epithelial Cells

5. IL-6 in Inflammation, Immunity, and Disease

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Significance of Vitamin Supplementation in Reducing the Severity of COVID-19;Mini-Reviews in Medicinal Chemistry;2024-02

2. Changes in chemokine and growth factor levels may be useful biomarkers for monitoring disease severity in COVID-19 patients; a pilot study;Frontiers in Immunology;2024-01-04

3. Predictions based on inflammatory cytokine profiling of Egyptian COVID-19 with 2 potential therapeutic effects of certain marine-derived compounds;International Immunopharmacology;2024-01

4. Angiotensin-Converting Enzyme-2 (ACE-2) with Interferon-Induced Transmembrane Protein-3 (IFITM-3) Genetic Variants and Interleukin-6 as Severity and Risk Predictors among COVID-19 Egyptian Population;International Journal of Microbiology;2023-12-21

5. Unveiling COVID-19 Secrets: Harnessing Cytokines as Powerful Biomarkers for Diagnosis and Predicting Severity;Journal of Inflammation Research;2023-12